Mantle Cell Lymphoma Mimicking Parotid Neoplasm: A Rare Case Report

Articles in Press

Document Type : Case Report

Authors

1 Department of Otorhinolaryngology (ENT), UPUMS, Saifai, Etawah, 206130. India.

2 Department of Otorhinolaryngology (ENT), Dr KNS Memorial Institute of Medical Science. Barabanki, Pin code: 225001, India.

3 Department of Pathology, UPUMS, Saifai, Etawah, 206130. India.

10.22038/ijorl.2025.88661.3973

Abstract

Introduction:
Mantle cell lymphoma (MCL) is a rare and aggressive B-cell non-Hodgkin lymphoma, commonly affecting lymph nodes, spleen, bone marrow, and gastrointestinal tract. Salivary gland involvement, especially in the parotid gland, is unusual and often mimics benign conditions, complicating diagnosis.
Case Report:
A 58-year-old male presented with a painless, progressively enlarging swelling in the right preauricular region without facial nerve involvement. Imaging revealed a mass within the parotid gland, leading to superficial parotidectomy. Histopathology confirmed mantle cell lymphoma. Immunohistochemical studies showed positivity for CD20, BCL2, CD5, and Cyclin D1; negativity for CD23, CD10, BCL6, and MUM1; and scattered CD3-positive T lymphocytes. The Ki-67 proliferation index was approximately 40%, indicating intermediate proliferative activity. Whole-body PET-CT revealed additional metabolically active lesions suggestive of systemic disease. The patient was started on bendamustine and rituximab chemotherapy.
Conclusion:
This case highlights that parotid swellings may conceal systemic lymphomas, and misleading cytology can delay diagnosis. Clinicians should consider MCL in atypical parotid lesions to ensure early systemic therapy.

Keywords

Main Subjects

References

  1. Campo E, Rule S. Mantle cell lymphoma: evolving management strategies. Blood. 2015 May 14;125(20):3212–20.
  2. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon: IARC; 2008.
  3. Ahmed S, Siddiqui AK, Rai KR. Low-grade mantle cell lymphoma involving the parotid gland: a rare presentation. Leuk Lymphoma. 2002; 43(10): 2107–10.
  4. Devaney K, Rinaldo A, Ferlito A. Lymphomas of the major salivary glands. Oral Oncol. 2006; 42(5):421–33.
  5. Hoster E, Dreyling M, Unterhalt M, Hasford J, Hiddemann W. A New Prognostic Index (MIPI) for Patients with Advanced Stage Mantle Cell Lymphoma. Blood. 2008; 111(2): 558-565. doi:10.1182/blood-2007-06-091151

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

  1. Lim SY, Dreyling M, Hoster E, et al. The Mantle Cell Lymphoma International Prognostic Index (MIPI) is superior to the International Prognostic Index (IPI) in predicting survival following intensive first-line immunochemotherapy and autologous stem cell transplantation. Blood. 2010; 115(15): 2926-2932. doi:10.1182/blood-2009-10-252149
  2. Marcucci M, Marcucci G, Cordeiro MS, León JE, Araujo JP, de Oliveira JX, Santos KC. Mantle cell lymphoma: involvement of nodal and extranodal sites in the head and neck, with multifocal oral lesions. Autopsy & Case Reports. 2017 Sep 30;7(3):26.
  3. Muscelli S, Ferri C, Della Porta MG, et al. Extranodal manifestation of mantle cell lymphoma in the oral cavity: a case report. Journal of Clinical and Experimental Hematopathology. 2023; 63(1): 41-44. doi:10.3960/jslrt.22007
  4. Hara S, Matsumoto Y, Murata T, et al. A case of mantle cell lymphoma detected with initial cytology of a palatal mass. Journal of Clinical and Experimental Hematopathology. 2025;65(1):25-28. doi:10.3960/jslrt.22012
  5. Lu J, Li Y, Zhang X, et al. Evaluation of second-generation Bruton's tyrosine kinase inhibitors in mantle cell lymphoma: a systematic review and network meta-analysis. Leukemia Research. 2025; 45:1-9. doi:10.1016/j. leukres.2025.03.001
Iranian Journal of Otorhinolaryngology

Articles in Press, Accepted Manuscript
Available Online from 25 December 2025

Files

Share

How to cite

Statistics